NASDAQ-GS · traded in Congress
Biogen BIIB
$253.68 +0.06 (+0.02%) Nov 2, 2026 4:05 AM ET
Market value$37.5B
P/E ratio-
Analyst target$260.00
52-week range-
Avg volume1,077,708
Dividend yieldN/A
Chart
Analyst ratings
- 25 buy
- 9 hold
- 1 sell
Low target$175.00
Average target$268.59
High target$350.00
Quarterly financials
| Quarter ended | Revenue | Gross profit | Net income | Net margin |
|---|---|---|---|---|
| $2,804M | - | $-21M | -0.7% | |
| $2,736M | - | $98M | 3.6% | |
| $2,478M | - | $320M | 12.9% | |
| $2,279M | - | $-49M | -2.2% |
Congress trades in BIIB
Members of Congress disclosed 7 transactions in BIIB in the filings we have processed.
| Traded | Member | Type | Amount | Filed |
|---|---|---|---|---|
| 09/24/2026 | Maria Elvira Salazar FL27 | Partial sale | $1,001 - $15,000 | 10/7/2026 filing |
| 08/18/2026 | Kevin Hern OK01 | Sale | $1,001 - $15,000 | 9/1/2026 filing |
| 06/05/2026 | Gilbert Cisneros CA31 | Purchase | $1,001 - $15,000 | 7/2/2026 filing |
| 06/02/2026 | Maria Elvira Salazar FL27 | Sale | $15,001 - $50,000 | 7/7/2026 filing |
| 05/12/2026 | Maria Elvira Salazar FL27 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
| 05/11/2026 | Maria Elvira Salazar FL27 | Purchase | $1,001 - $15,000 | 6/8/2026 filing |
| 05/11/2026 | Maria Elvira Salazar FL27 | Purchase | $50,001 - $100,000 | 6/8/2026 filing |
Disclosed under the STOCK Act. Amounts are the ranges the law requires, filings can lag a trade by up to 45 days, and a disclosure is not evidence of wrongdoing. All congressional trades ›
Other companies
Price and key figures from Nasdaq's public quote data, refreshed through the day; the chart is live from TradingView; options activity, ratings, financials, earnings and filings refreshed through the day. Congressional trades parsed from official House filings. Market information, not investment advice.
